Evidence map›Paper›PMID 35884149›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Towards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes.

Charles Okot Odongo, Lydia Nakiyingi, Clovis Gatete Nkeramihigo, Daniel Seifu, Kuteesa Ronald Bisaso

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Charles Okot OdongoDivision of Basic Medical Sciences, School of Medicine, University of Global Health Equity, Kigali P.O. Box 6955, Rwanda.
Lydia NakiyingiDepartment of Internal Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.ORCID 0000-0001-7263-3198
Clovis Gatete NkeramihigoDivision of Basic Medical Sciences, School of Medicine, University of Global Health Equity, Kigali P.O. Box 6955, Rwanda.
Daniel SeifuDivision of Basic Medical Sciences, School of Medicine, University of Global Health Equity, Kigali P.O. Box 6955, Rwanda.
Kuteesa Ronald BisasoBreakthrough Analytics Ltd., Plot 17B Gasper Oda Close, Naguru, Kampala, Uganda.
University of Global Health Equity · RWBreakthrough · USMakerere University · UG

Funding

NURTURE:Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health SciencesD43TW010132 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI SEWANKAMBO, NELSON K · 2015 to 2019
$4.3M
FIC NIH HHS D43 TW010132
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AUCCmaxpharmacokineticssepsistreatmenttuberculosis

Identifiers

PMID35884149
PMCPMC9311525
OpenAlexW4284703483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.